|Legal Status||Not Controlled|
No legal implications
Selective serotonin re-uptake inhibitor (SSRI). Used for the treatment of major depression, bulimia nervosa and obsessive-compulsive disorder.
|Short Term Effects||
Central nervous system features include tremor, agitation, dizziness, fatigue, drowsiness, coma and convulsions. Nausea, vomiting, dilated pupils and sweating may occur. Cardiovascular features seen with SSRIs include tachycardia, hypotension, hypertension, prolongation of QT interval and QRS duration, Torsade de Pointes, and cardiac arrest.
Death has been reported after ingestion of 6-12 g (Compton et al, 2005; Kincaid et al, 1990)
Identified in Sweden: 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one (norfludiazepam). Norfludiazepam is a benzodiazepine and is structurally related to the internationally controlled substance diazepam.
Some important news… : We are delighted to announce that WEDINOS has been fully funded by Welsh Government until 2025. This will not only ensure continuity of this important service but will allow for improvements and expansion in capacity and coverage through the purchase of new analytical tools. Please note that whilst this equipment is being installed, WEDINOS has to suspend testing for a limited period. Testing will resume at the beginning of May 2018 so your patience is required and we very much thank you for your continued support.